News

Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 ...
From new partnerships and launches, here are six developments from Globus Medical so far in 2025. 1. OsteoCentric Technologies entered into a non-exclusive licensing agreement with Globus Medical.
We'll examine a selection from our screener results. Overview: Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for musculoskeletal disorders ...
How Do Unusual Items Influence Profit? To properly understand Globus Medical's profit results, we need to consider the US$200m expense attributed to unusual items. While deductions due to unusual ...
AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share ...
Globus Medical, Inc. has announced a share repurchase program authorized by its Board of Directors, allowing the company to buy back up to $500 million of its outstanding common stock. Chief ...
Globus Medical’s board of directors authorized a share repurchase program of up to $500 million of the company’s outstanding common stock. Timing and number of repurchased shares will be determined by ...
General Medicine acts as an online health-care marketplace that can connect users with medical providers or assess what care they need based on symptoms.
AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share ...
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED).
Wexner, who is chairman of the board and for whom the medical center is named, said that "probably the largest AI investment in the world will happen in Columbus" and predicted that "100 more" medical ...